Status:

TERMINATED

Prevention of Infections in Cardiac Surgery

Lead Sponsor:

Hamilton Health Sciences Corporation

Collaborating Sponsors:

The Physicians' Services Incorporated Foundation

Conditions:

Thoracic Surgery

Antibiotic Prophylaxis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

There is clinical equipoise about the question of whether antibiotic prophylaxis should be given for a short period or an extended period of time as reflected by inconsistencies in major guidelines, c...

Eligibility Criteria

Inclusion

  • All adult patients (≥18 years of age) undergoing open-heart surgery (sternotomy, including minimally-invasive surgical techniques).

Exclusion

  • Patients on antibiotics at the time of surgery.
  • Previous enrollment in this trial.
  • Known MRSA carriers. Beta-lactam allergy (IgE-mediated) precluding the use of cefazolin
  • Participant in another study that may interfere with this trial.

Key Trial Info

Start Date :

April 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 10 2025

Estimated Enrollment :

5989 Patients enrolled

Trial Details

Trial ID

NCT02285140

Start Date

April 1 2015

End Date

March 10 2025

Last Update

March 12 2025

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Hamilton Health Sciences

Hamilton, Ontario, Canada, L8L 2X2

2

St. Michael's Hospital

Toronto, Ontario, Canada, M5B1W8

3

Jewish Hospital

Montreal, Quebec, Canada, H3T 1E2

4

University of Sherbrook

Sherbrook, Quebec, Canada, J1H 5N4